The Pharmaceutical Industry's Soul-Searching Question: Should You Kill Yourself?
Tang Que remained silent in the face of Williams' question, which was unusual for him.
Even someone as intelligent as him couldn't answer for a moment.
After a while, he patted Williams on the shoulder and said with a somewhat complicated expression.
"Big Wei, your question has stumped me. I'm afraid only President Wei is qualified to answer it."
"However, this is indeed a very good question, and it is a soul-searching question that every pharmaceutical company will face."
"After all, pharmaceutical companies often self-destruct. Some pharmaceutical companies' new drugs are so effective that they completely cure a disease. Then, a few years later, the drug is still there, but the patients are gone, the revenue is less, the stock price has fallen, and in the end, the company is gone too."
"I can only tell you from my own perspective that I really hope that humanity can completely eradicate these diseases."
"But from the company's perspective, or from the perspective of the entire industry, the answer may be completely different."
His tone suddenly turned serious as he said, "As researchers, we shouldn't waste our limited brain cells on such complex problems."
There is an old China saying, "Do good deeds and don't worry about the future."
"Today I'm giving you this advice: focus on your work and develop the drug first; we can talk about the rest later."
Williams pondered for a moment, then nodded and said, "I understand. Let's develop the drug first. At least then we'll have the paper and the bonus. As for whether the company will continue to exist, that's the boss's problem to consider, not ours."
"That... isn't wrong." Tang Que paused, looked at him, and said with a wry smile, "You're such a clever little devil."
That's what he said, but after watching Williams leave, the question took root in his mind.
For several days in a row, every time he finished his work, he would silently ask himself this question.
"If a drug to eradicate AIDS is actually developed, will the company bring it to market?"
"Severing Love Spirit is already perfect. It has completely turned AIDS into a controllable chronic disease that can generate a continuous stream of money. It can be described as the ideal drug in the eyes of pharmaceutical companies."
"With several years of sales, it can bring in billions of dollars in revenue for the company every year. Would the company be willing to give up such a blockbuster drug?"
"Perhaps, even if I develop my own HIV Gene Drug, the final outcome will be nothing more than being shelved, gathering dust in some cabinet, and waiting for many years without ever having the chance to be seen."
A host of questions lingered in his mind, and he seemed to already see the future of the project at hand.
Such things are not uncommon. Once a drug is developed, whether it can enter clinical trials and eventually be launched on the market depends on the company's decision.
Many drugs, despite their good efficacy, are not commercially viable and are therefore abandoned by pharmaceutical companies.
Large companies have many research and development projects under their control, so they will naturally be very careful in choosing drugs.
Small pharmaceutical companies typically have very few choices. When they only have one highly effective drug, they will not hesitate to launch it immediately, even if it means sacrificing their own safety, to seize the entire market. Even if patients disappear, they will at least make enough money.
Just like the rise of the antiviral giant Gilead, it was both made Hepatitis C destroyed by Hepatitis C.
Unlike established pharmaceutical companies like Johnson & Johnson & Pfizer and Pfizer, which are like octopuses dabble in multiple disease areas, this company is very focused. Since its inception, it has always concentrated on drugs for treating two types of viruses.
One type is AIDS, and the other is liver disease.
Why these two areas? The reason is simple: nearly one-third of people living with HIV also have Hepatitis Virus.
Therefore, Gilead is actually a unique player in the pharmaceutical industry that focuses solely on the field of antiviral drugs.
Hepatitis and AIDS alone have propelled it into the ranks of the world's top ten pharmaceutical giants, with annual revenue exceeding two billion US dollars.
Gilead was also in dire straits at the beginning. After the company was founded, it was slow to develop any drugs that could be brought to market.
Nine years later, the first drug was launched, and it took a full 14 years to turn a profit, finally showing the first net profit on the books.
From then on, the company's performance skyrocketed, dazzling everyone.
While the successful development of a series of AIDS drugs earned Gilead the reputation of an antiviral expert, it was the drug that cured Hepatitis C that truly made the company famous and solidified its position as a global antiviral giant.
After the launch of the "Gilead's first generation" anti- Hepatitis C virus miracle drug, the cure rate was directly raised from 50% to an unprecedented level, approaching 100%.
Therefore, in its first year on the market, it immediately swept the market and eliminated all competitors in the Hepatitis C drug market.
It brought in $6 billion in two quarters and sold a staggering $10.3 billion that year, making it the second best-selling drug in the world and creating a legend in the history of new drug sales.
Back then, market demand in the Eagle Country was extremely high, with as many as 140,000 patients taking the medication.
There's a reason why Gilead can make so much money; its drugs are extremely expensive.
A course of treatment with 'Gilead's first generation' costs $84,000, which works out to an average price of over $1,000 per pill.
The other new drugs that followed were even more expensive, costing $100,000 for a single course of treatment.
In the following years, Gilead launched the 'Gilead's second generation', 'Gilead's third generation', and 'Gilead's fourth generation' Hepatitis C drugs, covering all six genotypes of Hepatitis C virus. They can all quickly block the target virus, thereby eradicating Hepatitis C.
In just three or four years, Gilead virtually eradicated Hepatitis C.
The competition was in dire straits; all the giants, including Johnson & Johnson & Merck and Merck, announced the withdrawal of their Hepatitis C drugs from the market.
However, within a few years, Gilead found that its Hepatitis C drug sales began to decline rapidly.
Annual revenue plummeted from 30 billion to just over 20 billion, with Hepatitis C drug revenue halved.
Back then, the global market for anti -Hepatitis C virus drugs shrank by half.
The reason is simple: once all the patients are cured, the medicine can no longer be sold.
Hepatitis C is an infectious disease, and when patients are cured on a large scale, there will be signs of a rapid decline in the market.
The saying "When the birds are all gone, the good bow is put away" perfectly illustrates this point.
Even with all its efforts, Gilead could not reverse the company's decline.
The stock price has been declining from $125 all the way down to its current price of $60, and is still slowly falling.
If you follow someone else's path and leave them with no path to follow, you will eventually find yourself with no path to follow as well.
It can be said that Gilead has perfectly demonstrated this in the treatment of Hepatitis C.
However, when Gilead was developing its Hepatitis C drug, it was still relatively unknown. Faced with a blockbuster drug worth tens of billions of US dollars, it certainly couldn't think that much about it.
After 'Gilead's first generation' brought huge sums of money to the world's top ten pharmaceutical companies, they clearly learned from this experience and slowed down their progress in the development of anti-AIDS drugs.
Although they continue to make breakthroughs in other fields and develop new drugs to treat Hepatitis B, they are no longer trying to completely eradicate the disease, but rather taking the approach of having patients take medication for a long time.
Seeing Gilead's disastrous performance in the Hepatitis C drug field, other pharmaceutical companies will naturally reconsider and make their own choices in new drug development.
It's hard to imagine any other pharmaceutical company like Gilead would deliberately kill its own blockbuster drug.
Three Purities is now a mature pharmaceutical giant. It has finally gained a foothold in the anti-AIDS drug market, so why would it dig its own grave so quickly?
This is precisely what Tang Que is worried about. He is very concerned that the drug will be halted directly in the clinical trial stage after it is developed.
As the project leader, he hadn't thought much about it at first, because the development of Gene Drug wasn't going smoothly. He estimated it would take at least two years to produce results, and as for market launch, it would be at least three years from now.
Unexpectedly, a brilliant virus expert arrived. His abilities were so strong that he quickly broke through the project's bottlenecks, greatly advancing the research and development progress.
Based on this estimate, it shouldn't be long before the new drug is successfully developed.
Therefore, he needs to plan ahead and figure this out first.
After much deliberation, Tang Que finally arrived at Wei Kang's office and knocked on the door.
As soon as I entered, Wei Kang smiled and said, "I was just about to call you over. I have something to announce to you."
Tang Que then noticed that Chen Yiqing and Wenren Long were also sitting in the office.
Chen Yiqing smiled faintly and nodded to him.
Wenren Long winked at him and greeted him in a way they were familiar with.
Tang Que put his thoughts aside for the time being, sat down, and decided to listen to what his boss had to say.
Wei Kang took out a document and handed it to Chen Yiqing across from him. "Old Chen, take a look at this document and see if you are satisfied."
Chen Yiqing took it with a puzzled look and started looking through it.
As he watched, a look of shock appeared on his face, but he quickly broke into a wide grin, his smile revealing a strong sense of joy.
After a long pause, he reluctantly put down the documents, asking as if he couldn't believe it, "President Wei, is this true? The terms are unbelievably good."
Seeing that he was overjoyed, looking like he had been hit by a pie falling from the sky, Wenren Long couldn't help but shout, "Old Chen, what's the good news? Share it with your buddy!"
Wei Kang slowly opened his mouth and explained, "This is a company profit sharing agreement. As you all know, Old Chen has put a lot of effort into the new drug Neural Regeneration Factor. Although the drug is very successful and sells very well, he has also lost some well-deserved honors."
Chen Yiqing interjected, "Actually, I don't mind."
Wei Kang laughed, "I said that you will receive the honors and rewards you deserve, and now it's time to pay them off. As for the honors, it's hard to say, I'm still working on them and may not see them in the short term, but the rewards are right in front of you."
He tapped the table lightly with his finger and continued, "As everyone knows, I hold the majority of the shares in Sanqing Group, which is different from the equity structure of many technology companies."
"Over time, there will definitely be all sorts of rumors, saying that I took all the shares by myself, and the employees worked themselves to the bone but were still just employees who could not grow with the company and therefore had no sense of belonging."
"I can tell you all very clearly that this is indeed the case. Sanqing Group will belong to me alone in the future, and it will not be listed on the stock market, so there will be no opportunity to cash out."
"I have my own reasons for doing this. Pharmaceutical companies are different from other companies. They not only need to develop new drugs and earn high profits to survive in fierce competition, but also need to take on the social responsibility of treating and saving lives."
"Therefore, the Three Purities must never be swayed by any capital and do things that are purely profit-driven and contrary to conscience."
"That's why I refused to accept shares."
"In fact, I am very generous when it comes to giving money, even without shares, and everyone can see that."
"Of course, this amount of money may be enough for ordinary employees, but it is definitely not enough for senior executives."
"Therefore, I have drafted this profit-sharing agreement. How much money you receive in the future will depend entirely on your own abilities."
Wei Kang paused briefly, and seeing that the three of them were listening intently, he continued.
"Among all senior executives, you few laboratory directors are the company's most valuable Fortune and most important asset."
"The three of you who independently developed blockbuster new drugs, which generate annual revenue of over $1 billion, will each receive a dividend of one-thousandth of the company's annual net profit, based on your revenue share."
"Take the Neural Regeneration Factor developed by Old Chen as an example. Last year, it generated $3 billion in revenue, which is about 5% of the company's total revenue. If the company's profit margin is 50%, then the profit allocated to this drug at 5% would be $1.35 billion. One-thousandth of that would be $1.35 million. This is the dividend that Old Chen deserves."
"If this drug generates $10 billion in revenue annually and the company's profit margin is high enough, Old Chen's dividends will definitely increase, and may even reach tens of millions of dollars."
"Of course, the bonuses will only be paid out after three years of employment, and you will lose your eligibility after leaving the company. It can be considered as a benefit of growing together with the company."
"This money, while it won't make you rich like stocks, is still a considerable income."
"Given time, I believe your net worth will be no less than that of the internet upstarts."
No sooner had he finished speaking than Wenren Long exclaimed, "Holy crap! Old Chen has become a multi-millionaire without us even realizing it. It would be a real shame if he didn't invite us to his 'Big Sword' restaurant!"
Chen Yiqing's smile froze instantly. He waved his hand and said, "As long as President Wei is willing to go, I'll risk being scolded by my wife to invite you all."
"This..." Wenren Long said sullenly, "Consider it a narrow escape. I'll lower my demands a bit. How about we all go for a ride on a yacht on the island?"
Chen Yiqing smiled slightly and said, "Since that's the case, why not? Leave it to me. By the way, your Severing Love Spirit is selling extremely well. It will definitely become a blockbuster drug with a billion-dollar market value. Your share of the profits will be no less than mine."
Wenren Long said smugly, "Of course, I'm no pushover either."
He was all smiles, already planning how to spend this huge sum of money—he could buy flashy sports cars like Lamborghini and Ferrari.
Although A-Long earns a million-dollar annual salary, he also has high daily expenses, so it's still a bit difficult for him to spend a fortune on a supercar.
Now, I suddenly have a huge bonus every year, and my income has skyrocketed. I can afford some things that I used to only have a craving for.
"Indeed, the ancients were right. A horse won't get fat without night grass, and a person won't get rich without windfall gains!" Wenren Long thought to himself, envisioning a carefree life of shopping sprees, and couldn't help but feel a surge of emotions.
He reached out and patted Tang Que, winking smugly. "Brother Que, with so many Gene Drug, your share of the profits must be huge. None of the three of us missed out this time; we all made a fortune."
"Thank Severing Love Spirit, otherwise I would have been outdone this time. Hahaha."
Tang Que's eyes twitched involuntarily as he looked at Wenren Long's excited expression.
He knew that his Gene Drug were selling very well and would definitely break the $1 billion mark, especially the Thalassemia Gene Drug, which was simply a money tree.
However, this was not his main focus. "A-Long is so happy, that makes sense. Severing Love Spirit is his biggest gain in the company, so it must be very important to him, both in terms of achievements and money."
"If A-Long heard that AIDS could be completely eradicated and that Severing Love Spirit wouldn't sell for more than a few years, he would definitely be unhappy."
"I can't just pour cold water on him when he's in a good mood and tell him that he can get dividends this year but not next year."
Tang Que thought to himself, "Forget it, I shouldn't spoil this joyous occasion."
"Let's ask President Wei this question once the HIV Gene Drug therapy is nearly finished."
"Anyway, whether it goes public or not, there should be a result by then."
Thinking this, he looked at Wenren Long and forced an encouraging smile.
"A-Long, keep it up! You're the best. I believe you'll soon develop the next Billion Dollar Molecule."
Wenren Long felt a chill run down his spine. "Old Tang, don't be so mushy, it's giving me goosebumps."